rs117487814 - PDE3A: Glioblastoma association
Upload your raw genetic data once, we'll show you which variants you carry and what the research says.
Key takeaways
- This SNP is associated with Glioblastoma.
- The association has a reported effect size of 4.9 and p-value 4e-6.
- It was studied in about 9000 people.
- The evidence comes from a genome-wide association study.
Key takeaways
- This SNP is associated with Glioblastoma.
- The association has a reported effect size of 4.9 and p-value 4e-6.
- It was studied in about 9000 people.
- The evidence comes from a genome-wide association study.
What the research says This variant is associated with Glioblastoma, reported effect size 4.9, p=4e-6, in about 9 thousand individuals.[PMID 36810956]. The association was found using a genome-wide association study of this population.[PMID 36810956].
Reported associations Glioblastoma This variant is linked to the cancer, reported effect size 4.9 p=4e-6 in about 9000 individuals [PMID 36810956].
Evidence quality The study used a genome-wide association study of about 9000 participants and found this variant associated with Glioblastoma, effect size 4.9 p=4e-6. The evidence is strong but limited to this specific trait.[PMID 36810956]. No lifestyle considerations on file for this variant.
Frequently asked questions
Is rs117487814 linked to Glioblastoma?
Yes it is associated with Glioblastoma, effect size 4.9 p=4e-6 in about 9000 people.
Does this variant affect other conditions?
The study only reports association with Glioblastoma; no evidence for other conditions.
Can I get a risk score from this SNP?
This SNP alone is not used to calculate personal risk scores; it is part of broader genetic analysis.